中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [8]
合肥物质科学研究院 [6]
上海生物化学与细胞生... [4]
昆明动物研究所 [2]
化学研究所 [1]
大连化学物理研究所 [1]
更多
采集方式
OAI收割 [23]
iSwitch采集 [1]
内容类型
期刊论文 [24]
发表日期
2022 [2]
2021 [1]
2020 [2]
2018 [3]
2017 [4]
2015 [2]
更多
学科主题
Oncology [2]
Biotechnol... [1]
Respirator... [1]
Science & ... [1]
筛选
浏览/检索结果:
共24条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
OAI收割
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
  |  
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Utilization of genetic biomarkers testing and its associated factors in advanced colorectal cancer patients in China: a nationwide multicenter clinical epidemiological study
期刊论文
OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2022
作者:
Zhang, Xi
;
Lian, Xue-Mei
;
Gu, Xiao-Fen
;
Liu, Yin
;
Feng, Chang-Yan
  |  
收藏
  |  
浏览/下载:81/0
  |  
提交时间:2022/05/16
Colorectal cancer (CRC)
biomarker
RAS
BRAF
microsatellite instability (MSI)
Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:
Tao, Zhonghua
;
Liu, Jianxia
;
Li, Ting
;
Xu, Hong
;
Chen, Kai
  |  
收藏
  |  
浏览/下载:70/0
  |  
提交时间:2022/01/10
receptor tyrosine kinase
gene fusion
genomic rearrangments
breast cancer
next-generation sequencing
Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis
期刊论文
OAI收割
CANCER SCIENCE, 2020
作者:
Lan, Xiabin
;
Bao, Hua
;
Ge, Xinyang
;
Cao, Jun
;
Fan, Xiaojun
  |  
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2020/11/26
circulating tumor DNA
distant metastasis
mutation
nomogram
papillary thyroid carcinoma
Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients
期刊论文
OAI收割
ONCOTARGETS AND THERAPY, 2020, 卷号: 13
作者:
Wei, Weitian
;
Li, Xingliang
;
Song, Mengmeng
;
Wang, Changchun
  |  
收藏
  |  
浏览/下载:108/0
  |  
提交时间:2020/11/30
lung cancer
gene mutation
surgical margin
next-generation sequencing
AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness
期刊论文
OAI收割
Developmental cell, 2018
作者:
Wang, Xinbo
;
Jin, Jiali
;
Wan, Fangning
;
Zhao, Linlin
;
Chu, Hongshang
  |  
收藏
  |  
浏览/下载:180/0
  |  
提交时间:2019/01/08
Dysembryoplastic neuroepithelial tumor-like pilocytic astrocytoma: A case report
期刊论文
OAI收割
MEDICINE, 2018, 卷号: 97, 期号: 20, 页码: 4
作者:
Liao, Jia-Ming
;
Wang, Wei
;
Xie, Jing
;
Wu, Hai-Bo
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/08/26
dysembryoplastic neuroepithelial tumor
fluorescence in situ hybridisation
KIAA1549-BRAF fusion gene
pilocytic astrocytoma
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
期刊论文
OAI收割
EUROPEAN RADIOLOGY, 2018, 卷号: 28, 期号: 5, 页码: 2058-2067
作者:
Yang, Lei
;
Dong, Di
;
Fang, Mengjie
;
Zhu, Yongbei
;
Zang, Yali
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2018/10/10
Colorectal Neoplasms
Adenocarcinoma
Mutation
Diagnostic Imaging
Roc Curve
Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition
期刊论文
OAI收割
CANCER LETTERS, 2017, 卷号: 406, 页码: 105-115
作者:
Sun, Danni
;
Liu, Hongchun
;
Dai, Xiaoyang
;
Zheng, Xingling
;
Yan, Juan
  |  
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2019/01/08
Aspirin
mTORC1
AMPK
Sorafenib
Proliferation
AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes
期刊论文
OAI收割
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 卷号: 489, 期号: 1, 页码: 14-20
作者:
Wang, Hongbin
;
Quan, Haitian
;
Lou, Liguang
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/01/08
Antagonism
AKT
BRAF
Dabrafenib
Sorafenib